IBT
STML
International Biotechnology Trust’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-965,245
| Closed | -$10.3M | – | 70 |
|
|
2019
Q4 | $10.3M | Buy |
965,245
+130,000
| +16% | +$1.38M | 3.69% | 9 |
|
|
2019
Q3 | $8.7M | Buy |
835,245
+91,000
| +12% | +$947K | 4.02% | 8 |
|
|
2019
Q2 | $11.4M | Sell |
744,245
-52,000
| -7% | -$797K | 4.23% | 8 |
|
|
2019
Q1 | $10.2M | Buy |
796,245
+210,315
| +36% | +$2.7M | 3.78% | 4 |
|
|
2018
Q4 | $4.37M | Hold |
585,930
| – | – | 2.71% | 14 |
|
|
2018
Q3 | $7.46M | Buy |
585,930
+93,000
| +19% | +$1.18M | 3.55% | 9 |
|
|
2018
Q2 | $7.86M | Hold |
492,930
| – | – | 3.02% | 13 |
|
|
2018
Q1 | $7.52M | Hold |
492,930
| – | – | 2.93% | 13 |
|
|
2017
Q4 | $7.69M | Buy |
492,930
+310,000
| +169% | +$4.84M | 2.71% | 13 |
|
|
2017
Q3 | $2.03M | Sell |
182,930
-270,070
| -60% | -$3M | 0.79% | 34 |
|
|
2017
Q2 | $4.17M | Buy |
453,000
+123,000
| +37% | +$1.13M | 1.58% | 21 |
|
|
2017
Q1 | $2.81M | Buy |
+330,000
| New | +$2.81M | 1.07% | 26 |
|